SECTOR : Healthcare facilities
ENTRY DATE : 2007
EXIT DATE : 2013
BUSINESS : Venture Capital
WEB : www.eos-imaging.com
An entirely new concept of imaging for orthopaedics
EOS imaging is a medical imaging company that is revolutionising the treatment continuum for the most common osteoarticular conditions (hip, knee and spine) and associated orthopaedic surgeries. Its EOS® product is an offshoot of the work by Georges Charpak, a Nobel laureate for physics.
The group has obtained marketing approvals in 32 countries, including the United States (FDA), Canada, Australia and the European Union (CE). The group is headquartered in Paris and has four subsidiaries: in France (Besançon), the United States (Cambridge), Canada (Montreal) and Germany, as well as an office in Singapore.
June 2012: EOS imaging (EOSI) successfully completed its IPO, raising €38 million.
Market capitalisation at IPO date: €120 million
PRESS RELEASE(S) :
10/02/2016 • Omnes Capital sells a portfolio of more than 100 MW of renewable energy assets to EOS Holding